Galmed Pharmaceuticals (GLMD) EBIT Growth (3y) (2016 - 2020)
Galmed Pharmaceuticals (GLMD) EBIT Growth (3y) (2016 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
25.57% |
| Dec 31, 2019 |
19.15% |
| Sep 30, 2019 |
5.86% |
| Mar 31, 2019 |
-0.51% |
| Dec 31, 2018 |
4.96% |
| Sep 30, 2018 |
-38.25% |
| Jun 30, 2018 |
0.86% |
| Mar 31, 2018 |
0.73% |
| Dec 31, 2017 |
22.59% |
| Sep 30, 2017 |
-3.72% |
| Jun 30, 2017 |
15.02% |
| Mar 31, 2017 |
15.20% |
| Jun 30, 2016 |
64.51% |
| Mar 31, 2016 |
89.49% |
